Chronic administration of bacopa monniera increases BDNF protein and mRNA expressions: A study in chronic unpredictable stress induced animal model of depression

Psychiatry Investigation

Volumn 11, Issue 3, 2014, Pages 297-306

  Banerjee, Ritabrata ^a   Hazra, Somoday ^a   Ghosh, Anup Kumar ^b   Mondal, Amal Chandra ^a  

^a Raja Peary Mohan College   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Antidepressant; Bacopa monniera; BDNF; Chronic unpredictable stress; Open field test; Shuttle box escape test; Sucrose consumption; TrkB

Indexed keywords

BACOPA MONNIERI EXTRACT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; IMIPRAMINE; MESSENGER RNA;

ADRENAL GLAND; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BODY WEIGHT; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; EXPERIMENTAL BEHAVIORAL TEST; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; RAT; SHUTTLE BOX ESCAPE TEST; SUCROSE PREFERENCE TEST; WESTERN BLOTTING;

EID: 84905483486     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2014.11.3.297     Document Type: Article

References (33)

1. Hankin BL. Adolescent depression: description, causes, and interventions. Epilepsy Behav 2006; 8: 102-114.
2. Perahia DG, Quail D, Desaiah D, Montejo AL, Schatzberg AF. Switching to duloxetine in selective serotonin reuptake inhibitor non-and partialresponders: effects on painful physical symptoms of depression. J Psychiatry Res 2009; 43: 512-518.
3. Banerjee R, Ghosh AK, Ghosh B, Mondal AC. Female-specific depression induction in learned-helplessness model of rats. Int J Bioeng Sci Tech 2011a; 2: 51-59.
4. Banerjee R, Ghosh AK, Ghosh B, Mondal AC. Stress: the negative modulator of NGF. Res Rev: A J Life Sci 2011b; 1: 1-9.
5. Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res 2005; 53: 129-139.
6. Castrén E, Võikar V, Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007; 7: 18-21.
7. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131-137.
8. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brainderived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068-1072.
9. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1256-1260.
10. Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A. Serum brain-derived neurotrophic factor level in dysthymia: A comparative study with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1023-1026.
11. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75.
12. Basterzi AD, Yazici K, Aslan E, Delialioglu N, Tasdelen B, Tot Acar S, et al. Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 281-285.
13. Lee BH, Kim YK. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig 2010; 7: 231-235.
14. Lee HY, Kim YK. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008; 57: 194-199.
15. Banerjee R, Ghosh AK, Ghosh B, Mondal AC. Chronic administration of Fluoxetine ameliorates depression: Enhanced BDNF and its receptor TrkB expressions with down stream signalling cascades ERK1/2 and Akt pathways. J Pharm Biomed Sci 2013; 30: 975-985.
16. Banerjee R, Ghosh AK, Ghosh B, Batabyal S, Mondal AC. Effects of chronic mild stress on brain derived neurotrophic and nerve growth factors in the rat hippocampus. Neurosci Res Lett 2012; 3: 29-34.
17. Zhang ZJ. Therapeutic effects of herbal extracts and constiturnts in animal models of psychiatric disorders. Life Sci 2004; 75: 1659-1699.
18. Udupa KN, Singh RH. Clinical and Experimental Studies on Rasayana drugs and Panchkarma Therapy. New Delhi: Central Council for Research in Ayurveda and Siddha; 1995.
19. Hazra S, Banerjee R, Das BK, Ghosh AK, Banerjee TK, Hazra US, et al. Evaluation of antidepressant activity of Bacopa monnieri in rat: a study in animal model of depression. Drug Discov 2012; 2: 8-13.
20. Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 2005; 12: 305-317.
21. Mao QQ, Ip SP, Ko KM, Tsai SH, Xian YF, Che CT. Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant like activity. J Ethnopharmacol 2009; 124: 316-320.
22. Luo DD, An SC, Zhang X. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Res Bull 2008; 77: 8-12.
23. Mao QQ, Ip SP, Tsai SH, Che CT. Antidepressant like effect of peony glycosides in mice. J Ethnopharmacol 2008; 119: 272-275.
24. Katz RJ, Roth KA, Schmaltz K. Amphetamine and tranylcypromine in an animal model of depression: pharmacological specificity of the reversal effect. Neuroscience Biobehav Rev 1981; 5: 259-264.
25. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10year review and evaluation. Psychopharmacology (Berl) 1997; 134: 319-329.
26. Willner P. Chronic mild stress (CMS) revisited: consistency and behaviouralneurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90-110.
27. Li S, Wang C, Wang M, Li W, Matsumoto K, Tang Y. Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sci 2007; 80: 1373-1381.
28. Zhao Z, Wang W, Guo H, Zhou D. Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats. Behav Brain Res 2008; 194: 108-113.
29. D'Aquila PS, Peana AT, Carboni V, Serra G. Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine. Eur J Pharmacol 2000; 399: 43-47.
30. Qi X, Lin W, Li J, Li H, Wang W, Wang D, et al. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressivelike behavior in rats exposed to chronic forced swim stress. Neurobiol Dis 2008; 31: 278-285.
31. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001; 35: 45-49.
32. Fuchs E, Czeh B, Kole MH, Michaelis T, Lucassen PJ. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 2004; 14(Suppl 5): S481-S490.
33. Yulug B, Ozan E, Gönül AS, Kilic E. Brain-derived neurotrophic factor, stress and depression: a minireview. Brain Res Bull 2009; 78: 267-269.